Citi ka support, target ₹9,600!
Citi brokerage ne Apollo Hospitals ko itna support diya hai ki unhone stock ko apni 'Asia Focus List' mein shamil kar liya hai aur 'buy' rating bhi maintain rakhi hai. Iske saath hi, unhone share ka target price badha kar ₹9,600 kar diya hai, jo current levels se 34% aur upar jaane ka ishara de raha hai!
Citi kyu hai itna bullish?
Citi ke analysts ko Apollo ka core hospital business stable lag raha hai aur unka digital pharmacy business bhi achha profit kama raha hai. Valuation bhi kaafi attractive lag raha hai, matlab average se kam price par mil raha hai.
Q3 Results bhi zabardast!
Company ke December quarter ke results bhi market expectations se better aaye hain. Net profit 35% badh kar ₹502.3 Crore ho gaya, jabki revenue 17.2% badh kar ₹6,477 Crore tak pahunch gaya. EBITDA bhi 26.7% badha aur margin bhi 14.9% ho gaya, jo pichhle saal 13.8% tha.
Baaki analysts kya keh rahe hain?
Sirf Citi hi nahi, baaki analysts bhi Apollo Hospitals ko lekar kaafi positive hain. Total 30 analysts mein se 27 log 'buy' karne ko keh rahe hain, bas 2 hold karne ko aur sirf 1 sell karne ko bol raha hai. Aaj share 4.3% upar ₹7,455 par trade kar raha hai, aur saal ki shuruaat se ab tak 5% gain kar chuka hai.